| abstract |
Bispecific binding molecules binding to VEGF and Ang2 Abstract Bispecifc binding molecules binding to both VEGF and Ang2, preferably in 5 the form of immunoglobulin single variable domains like VHHs and domain antibodies, pharmaceutical compositions containing the same and their use in the treatment of diseases that are associated with VEGF- and/or Ang2 mediated effects on angiogenesis are disclosed. Further, nucleic acids encoding bispecific binding molecules, host cells and methods for preparing 10 same are also described. |